Cadence Neuroscience, Inc. is a clinical-stage medical device company founded in 2017 and headquartered in Redmond, Washington, developing a personalized neuromodulation system for pediatric and adult patients with focal drug-resistant epilepsy. Its implantable system, licensed from Mayo Clinic and incubated by a Mayo Clinic Rochester neurology and neurosurgery team, delivers chronic subthreshold cortical stimulation and detects EEG biomarkers of epileptiform activity in order to reduce or eliminate seizures. The company raised a $15M Series A in 2019 and a $26M Series B in 2023 led by the Angelini Lumira Biosciences Fund, with participation from F-Prime Capital, LivaNova USA, Angelini Ventures, Spectrum Financial Services and Mayo Clinic, and is using the proceeds to complete pivotal clinical studies and pursue FDA clearance. It is a regulated medical device manufacturer rather than a software vendor: it publishes no developer portal, public API, SDK or machine-readable API contract.
Cadence Neuroscience is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Neurotechnology, and Neuromodulation.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: cadence-neuroscience
name: Cadence Neuroscience
description: 'Cadence Neuroscience, Inc. is a clinical-stage medical device company founded in 2017 and headquartered in Redmond,
Washington, developing a personalized neuromodulation system for pediatric and adult patients with focal drug-resistant
epilepsy. Its implantable system, licensed from Mayo Clinic and incubated by a Mayo Clinic Rochester neurology and neurosurgery
team, delivers chronic subthreshold cortical stimulation and detects EEG biomarkers of epileptiform activity in order to
reduce or eliminate seizures. The company raised a $15M Series A in 2019 and a $26M Series B in 2023 led by the Angelini
Lumira Biosciences Fund, with participation from F-Prime Capital, LivaNova USA, Angelini Ventures, Spectrum Financial Services
and Mayo Clinic, and is using the proceeds to complete pivotal clinical studies and pursue FDA clearance. It is a regulated
medical device manufacturer rather than a software vendor: it publishes no developer portal, public API, SDK or machine-readable
API contract.'
url: https://raw.githubusercontent.com/api-evangelist/cadence-neuroscience/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.23'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Medical Devices
- Healthcare
- Neurotechnology
- Neuromodulation
- Epilepsy
- Medical Technology
- Clinical Stage
tags_raw:
- Company
- Medical Devices
- Health Care
- Neurotechnology
- Neuromodulation
- Epilepsy
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/cadence-neuroscience-domain-security.yml
- type: Website
url: https://cadenceneuro.com/
- type: LinkedIn
url: https://www.linkedin.com/company/cadence-neuroscience-inc
- type: Crunchbase
url: https://www.crunchbase.com/organization/cadence-neuroscience
- type: SecondaryMarket
url: https://www.nasdaqprivatemarket.com/
x-enrichment:
date: '2026-08-08'
status: minimal
artifacts_added: 1
pass: local-v1
x-coverage:
state: blocked
reason: bot-challenge
detail: Every path on cadenceneuro.com — homepage, /llms.txt and all /.well-known/* probes — answered HTTP 202 with a SiteGround
anti-bot interstitial (a 169-byte meta-refresh to /.well-known/sgcaptcha/ carrying the sg-captcha challenge header) instead
of the page, so not one page of the company's own surface could be read; DNS/TLS probes and third-party sources still
completed.
evidence:
- url: https://cadenceneuro.com/
status: 202
- url: https://cadenceneuro.com/llms.txt
status: 202
- url: https://cadenceneuro.com/.well-known/security.txt
status: 202
- url: https://cadenceneuro.com/.well-known/agent-card.json
status: 202
checked: '2026-08-08'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →